Adagio Medical Holdings Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Adagio Medical Holdings, Inc. (ADGM) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021
Period EndingDec 2024Dec 2023Dec 2022Dec 2021
Operating Activities
Net Income-75.04-36.59-23.67-19.94
Depreciation & Amortization1.390.530.500.34
Deferred Income Tax-1.920.000.000.00
Stock Based Compensation0.000.440.370.34
Change in Working Capital5.792.790.330.58
Change in Accounts Receivable0.04-0.070.030.04
Change in Inventory0.63-2.980.04-0.47
Change in Accounts Payable-4.562.820.440.28
Change in Other Working Capital9.693.01-0.170.73
Other Operating Activities40.337.160.07-0.62
Net Cash from Operating Activities-29.46-25.65-22.41-19.31
Investing Activities
Capital Expenditures-1.65-0.33-0.49-1.27
Sales/Maturities of Investments0.00-0.01-0.01-0.01
Net Cash from Investing Activities-1.65-0.34-0.50-1.27
Financing Activities
Debt Repayment15.63-1.140.000.00
Common Stock Issued0.000.020.030.13
Net Cash from Financing Activities15.6321.889.530.13
Summary
Effect of Forex Changes on Cash36.04-0.050.080.07
Net Change in Cash20.57-4.16-13.31-20.45
Cash at Beginning of Period0.025.5518.8539.23
Cash at End of Period20.591.385.5518.85
Free Cash Flow-31.11-25.99-22.90-20.58
Supplemental Disclosures
Interest Paid0.090.210.000.00